Baldoza, Danilo R.
HRN: 23-31-09 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2023
MEBENDAZOLE 500MG (TAB)
08/15/2023
08/15/2023
PO
Single Dose
Single Dose
Heptic Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes